medigraphic.com
SPANISH

Revista Cubana de Hematología, Inmunología y Hemoterapia

ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2022; 38 (1)

Analysis of radiological risks in diagnostic nuclear medicine of the Institute of Hematology and Immunology of Cuba

Amador BZH, Torres VA, Fundora STA
Full text How to cite this article

Language: Spanish
References: 21
Page: 1-14
PDF size: 629.17 Kb.


Key words:

risk assessment, risk matrix, hematology, SPECT.

ABSTRACT

Introduction: For the start of operations in the nuclear medicine service of the Institute of Hematology and Immunology, the analysis of radiological risks carried out.
Objectives: To determine the individual contribution of the stages of the process and of the control elements in the radiological risk.
Methods: The developed process model was from the risk matrix method. The added measures were at eliminating accidental sequences with medium risk and high consequences for the patients. The most important control elements were by their percentage participation and incidence in the change in the level of risk when they eliminated.
Results: The stages most contributing to the risk were, in order of importance, the preparation of the radiopharmaceuticals, the acquisition of the images and the administration. Highlighted measures are the following: a moderate workload, the training for the radiation protection officer and the one who performs the administrations and the procedure of contrasting the data of the dose that will administer to the patient against what is in the study prescription. Besides are the tests quality control of radiopharmaceuticals, the analysis of the results of the dosimetry performed on the workers periodically and the external and internal audits with different equipment.
Conclusions: All the measures identified in obtaining the residual risk and in the sensitivity analysis, were included in the Safety and Quality Improvement Plan, as a guarantee of the radiological safety of the operations.


REFERENCES

  1. Ministerio de Ciencia, Tecnología y Medio Ambiente. Reglamento sobre Notificación y Autorización de Prácticas y Actividades Asociadas al Empleo de Fuentes de Radiaciones Ionizantes. La Habana, Cuba 2012.

  2. Muzzalupo R. Tc-99m External Contamination US Nuclear Regulatory Commssion. Event Number: 54947, 2020. [acceso 25/10/2020]; Disponible en: Disponible en: https://www.nrc.gov/reading-rm/doc-collections/event-status/event/2020/20201022en.html#en54947

  3. Chippo J. Missing Licensed Material US Nuclear Regulatory Commission. Event Number: 54964, 2020. [acceso 15/11/2020]; Disponible en: Disponible en: https://www.nrc.gov/reading-rm/doc-collections/event-status/event/2020/20201030en.html#en54964

  4. RELIR-OTHEA. Medical sector-Nuclear medicine. Contamination of a nuclear medicine technician with Technetium-99. 2019. [acceso 16/3/2021]; Disponible en: Disponible en: https://relir.cepn.asso.fr/en/reports/medical-and-veterinary/nuclear-medicine/272-contamination-of-a-nuclear-medicine-technician-with-technetium-99.html

  5. Martin C, Marengo M, Vassileva J, Giammarile F, Poli G, Marsk P. Guidance on prevention of unintended and accidental radiation exposures in nuclear medicine. J Radiol Prot 2019;39(3):665-95.

  6. Mckenzie J. Administration of Dose to Wrong Individual. US Regulatory Nuclear Commission. Event Number: 54344, 2019. [acceso 15/11/2019]; Disponible en: Disponible en: https://www.nrc.gov/reading-rm/doc-collections/event-status/event/2019/20191030en.html#en54344

  7. Rubadue M. Mo-99/Tc-99 Breakthrough Limit Exceeded. US Nuclear Regulatory Commission. Event Number:53931, 2018. [acceso 25/4/2019]; Disponible en: Disponible en: https://www.nrc.gov/reading-rm/doc-collections/event-status/event/2019/20190321en.html#en53931

  8. Huffman C. Spill of Tc-99m Vial in Hot Lab. US Regulatory Nuclear Commission. Event Number: 53806, 2018. [acceso 15/2/2019]; Disponible en: Disponible en: https://www.nrc.gov/reading-rm/doc-collections/event-status/event/2019/20190103en.html#en53806

  9. Canadian Regulatory Commission. Dose limit exceedance for a Nuclear Energy Worker Windsor Regional Hospital Ouellette Campus, Windsor, Ontario. Event date: February 13 2017 [acceso 15/11/2019]; Disponible en: Disponible en: http://www.nuclearsafety.gc.ca/eng/acts-and-regulations/event-reports-for-major-nuclear-facilities/event-reporting/nuclear-medicine.cfm

  10. Organismo Internacional de Energía Atómica y Foro Iberoamericano de Organismos Reguladores en Seguridad Nuclear, Radiológica y Física. Aplicación de la Matriz de Riesgo a la Radioterapia. IAEA-TECDOC 1685/S. Viena, Austria, 2012.

  11. López Morones R, Duménigo González C, Espinosa MA, Cruz R, Papadopulos S, Joana G. Overview of Risk Models and Results Obtained by Foro Project (SEVRRA 2) For IMRT and DNM Techniques. In: IAEA, editor. (Virtual event) International Conference on Radiation Safety: Improving Radiation Protection in Practice;(09-20)/11/2020; Vienna, Austria: IAEA;2020. https://conferences.iaea.org/event/213/.

  12. Duménigo C, López Morones R, Ramírez M, Papadópulos S, et al. Metodología de Matrices de Riesgo. Actualización de la Misma Basada en las Experiencias en su Aplicación. XI Congreso Regional de Seguridad Radiológica y Nuclear Congreso Regional IRPA “Cultura de Seguridad: un compromiso compartido”;16 al 20 de abril de 2018; La Habana, Cuba 2018. https://inis.iaea.org/search/search.aspx?orig_q=RN:50030409.

  13. Duménigo C, Bosch R, De La Fuente Puch A, Pérez Y, Quevedo J. Estimaciones de Riesgo con el Uso de SEVRRA. Análisis de Resultados. La Perspectiva del Usuario y del Regulador. XI Congreso Regional de Seguridad Radiológica y Nuclear Congreso Regional IRPA “Cultura de Seguridad: un compromiso compartido”;16 al 20 de abril de 2018. La Habana, Cuba 2018. https://inis.iaea.org/search/search.aspx?orig_q=RN:50030409.

  14. Duménigo C, Guerrero M, López Morones R, Paz A. Matrices de Riesgo en Medicina Nuclear. Modelación en SEVRRA. X Congreso Regional Latinoamericano IRPA de Protección y Seguridad Radiológica “Radioprotección: Nuevos Desafíos para un Mundo en Evolución”;12 al 17 de abril, 2015. Buenos Aires, Argentina 2015. [acceso 12/8/2020]; Disponible en: Disponible en: http://www.irpabuenosaires2015.org/Archivos/tr-completos/

  15. Duménigo C, Guerrero M, Cruz Y, Soler K. Evaluaciones de seguridad de la práctica de Medicina Nuclear utilizando el método de matrices de riesgo. IX Congreso Latinoamericano del IRPA; Río de Janeiro, Brasil 2013.

  16. Torres Valle A. Manual de Usuario SECURE-MR-FMEA 3.0. Programa de análisis de riesgo basado en matriz de riesgo y FMEA. La Habana, Cuba; 2017. http://nucleus.cubaenergia.cu/index.php/nucleus/article/view/727/944.

  17. Centro Nacional de Seguridad Nuclear. Guía Expectativas del Organismo Regulador sobre la Cultura de Seguridad en las Organizaciones que Realizan Actividades con Fuentes de Radiación Ionizante. La Habana 2015. https://www.facebook.com/orsacitma.cu/.

  18. International Atomic Energy Agency. Radiation Safety Culture Trait Talks. Handbook, Vienna 2021. [acceso 03/1/2021]; Disponible en: Disponible en: https://www.iaea.org/sites/default/files/21/01/radiation-safety-culture-trait-talks.pdF

  19. Vaño E, Jiménez P, Ramírez R, Zarzuela J, et al. Main problems and suggested solutions for improving radiation protection in medicine in Ibero-American countries. Summary of an International Conference held in Madrid, 2016. J Radiol Prot. 2018;38:109-20. DOI: https://doi.org/10.1088/1361-6498/aa914A

  20. Calderón Marín, C, González González, J, Duménigo, C, Quesada Cepero, W, et al. Análisis de seguridad radiológica de una instalación PET/CT mediante el empleo de la matriz de riesgo. Nucleus. 2017;62:38-42. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-084X2017000200008

  21. International Atomic Energy Agency. Nuclear Medicine Resources Manual. 2020 Edition. IAEA Human Health Series. Marketing and Sales Unit, Publishing Section. 37: 175 IAEA, Vienna 2020 [acceso 03/01/2021]; Disponible en: Disponible en: https://www-pub.iaea.org/MTCD/Publications/PDF/PUB/1861.pdf




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Hematol Inmunol Hemoter . 2022;38